Welsh, P., Grassia, G., Botha, S., Sattar, N., & Maffia, P. (2017). Targeting inflammation to reduce cardiovascular disease risk: A realistic clinical prospect? British Journal of Pharmacology, 174(22), 3898. https://doi.org/10.1111/bph.13818
Chicago Style (17th ed.) CitationWelsh, Paul, Gianluca Grassia, Shani Botha, Naveed Sattar, and Pasquale Maffia. "Targeting Inflammation to Reduce Cardiovascular Disease Risk: A Realistic Clinical Prospect?" British Journal of Pharmacology 174, no. 22 (2017): 3898. https://doi.org/10.1111/bph.13818.
MLA (9th ed.) CitationWelsh, Paul, et al. "Targeting Inflammation to Reduce Cardiovascular Disease Risk: A Realistic Clinical Prospect?" British Journal of Pharmacology, vol. 174, no. 22, 2017, p. 3898, https://doi.org/10.1111/bph.13818.